Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis
Background: The long-term risk for major bleeding in patients receiving extended (beyond
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Systematic Review and Meta …
F Khan, T Tritschler, M Kimpton… - Annals of internal …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The long-term risk for major bleeding in patients receiving extended (beyond
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis
F Khan, T Tritschler, M Kimpton… - ANNALS OF …, 2021 - irinsubria.uninsubria.it
Background: The long-term risk for major bleeding in patients receiving extended (beyond
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Systematic Review and Meta …
F Khan, T Tritschler, M Kimpton, PS Wells… - Annals of Internal …, 2021 - europepmc.org
Background The long-term risk for major bleeding in patients receiving extended (beyond
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis
F Khan, T Tritschler, M Kimpton, PS Wells… - ANNALS OF …, 2021 - research.unipg.it
Background: The long-term risk for major bleeding in patients receiving extended (beyond
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
[引用][C] Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism
F Khan, T Tritschler, M Kimpton, PS Wells… - Annals of Internal …, 2021 - cir.nii.ac.jp
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First
Unprovoked Venous Thromboembolism | CiNii Research CiNii 国立情報学研究所 学術情報 …
Unprovoked Venous Thromboembolism | CiNii Research CiNii 国立情報学研究所 学術情報 …
Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis
F Khan, T Tritschler, M Kimpton… - Annals of …, 2021 - researchinformation.amsterdamumc …
Background: The long-term risk for major bleeding in patients receiving extended (beyond
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis
F Khan, T Tritschler, M Kimpton, PS Wells… - ANNALS OF …, 2021 - cris.unibo.it
Background: The long-term risk for major bleeding in patients receiving extended (beyond
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Systematic Review and Meta …
F Khan, T Tritschler, M Kimpton, PS Wells… - Annals of internal …, 2021 - boris.unibe.ch
BACKGROUND The long-term risk for major bleeding in patients receiving extended
(beyond the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
(beyond the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Systematic Review and Meta …
CA Bradbury - Annals of Internal Medicine, 2021 - research-information.bris.ac.uk
Background: The long-term risk for major bleeding in patients receiving extended (beyond
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …
the initial 3 to 6 months) anticoagulant therapy for a first unprovoked venous …